Physician profile
Ann T Bartee
NPI 1730569328
$1,670.98
in general payments reported to CMS, 2019-2025
17 companies · $77.41 in 2025
The $77.41 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.06 · 2022: $276 · 2023: $607 · 2024: $675 · 2025: $77.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $335.02 | 2021-2024 | |
| Exact Sciences Corporation | $235.97 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $169.05 | 2023-2024 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $145.34 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $142.76 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $119.20 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $113.94 | 2022-2024 | Farxiga, Breztri |
| Dexcom, INC. | $81.18 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $56.73 | 2022-2024 | Zepbound, Jardiance |
| Amgen INC. | $56.19 | 2022-2025 | Prolia, Evenity, Otezla |
| Novartis Pharmaceuticals Corporation | $47.36 | 2022-2023 | |
| Pfizer INC. | $46.90 | 2024 | |
| Esperion Therapeutics, INC. | $35.55 | 2024 | Nexletol |
| Teva Pharmaceuticals USA, INC. | $33.70 | 2022 | |
| Gt Medical Technologies, INC | $21.11 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.93 | 2024 | Intellis Adaptivestim |
| Inari Medical, INC. | $14.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Bartee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.